SMA Drug Pipeline
Using this drug pipeline, we are tracking the development of all possible SMA treatments currently being tested in human clinical trials.
The diagram is split into:
- drugs that do not affect SMN protein levels (SMN-independent)
- drugs that increase SMN protein levels (SMN-dependent).
The diagram will be regularly updated to map the development and progress of each drug programme.
Last updated January 2018